Medtronic Plc [NYSE: MDT] closed the trading session at $87.92.
The stocks have a year to date performance of 10.07 percent and weekly performance of 0.54 percent. The stock has been moved at 6.03 percent over the last six months. The stock has performed 2.10 percent around the most recent 30 days and changed -5.82 percent over the most recent 3-months.
If compared to the average trading volume of 7.94M shares, MDT reached to a volume of 8408384 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Medtronic Plc [MDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $94.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.23. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Medtronic Plc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Citigroup dropped their target price from $92 to $107. The new note on the price target was released on March 04, 2025, representing the official price target for Medtronic Plc stock. Previously, the target price had yet another raise from $98 to $105, while RBC Capital Mkts kept a Outperform rating on MDT stock. On August 21, 2024, analysts increased their price target for MDT shares from 92 to 94.
The Average True Range (ATR) for Medtronic Plc is set at 1.48, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 3.36. The Price to Book ratio for the last quarter was 2.35, with the Price to Cash per share for the same quarter was set at 6.99. Price to Free Cash Flow for MDT in the course of the last twelve months was 21.75 with Quick ratio for the last quarter at 1.42.
MDT stock trade performance evaluation
Medtronic Plc [MDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.54. With this latest performance, MDT shares gained by 2.10% in over the last four-week period, additionally plugging by 6.03% over the last 6 months – not to mention a rise of 6.92% in the past year of trading.
Medtronic Plc [MDT]: An insightful look at the core fundamentals
Medtronic Plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.42 and a Current Ratio set at 1.85.
Earnings per share (EPS) analysis for Medtronic Plc [MDT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic Plc go to 5.54%.
Medtronic Plc [MDT]: Institutional Ownership
The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 126.61 million shares, which is approximately 9.7895%. BLACKROCK INC., holding 111.89 million shares of the stock with an approximate value of $$8.81 billion in MDT stocks shares; and BLACKROCK INC., currently with $$4.78 billion in MDT stock with ownership which is approximately 4.6556%.
